Seres Therapeutics, Inc.
$4.21
-$0.39 (-8.48%)
$4.18Day Range$4.83
Key Statistics
Market Cap
$46.21M
Shares Outstanding
10.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 26, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$4.55
Day High
$4.83
Day Low
$4.18
Volume
83.8K
VWAP
$4.38
Prev Close
$4.60
Transactions
--
Acc. Volume
--
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
PHARMACEUTICAL PREPARATIONSSIC 283466 employees200 SIDNEY STREET, CAMBRIDGE, MA, 02139617 945 9626IPO Jun 26, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001609809
- Composite FIGI
- BBG0099X6859
- Share Class FIGI
- BBG0099X6868
- Ticker Root
- MCRB
- SIC Code
- 2834
About Seres Therapeutics, Inc. (MCRB) Stock
Seres Therapeutics, Inc. (MCRB) closed the 2026-09-16 session at $4.21, down 8.48% versus the previous close (-0.39). The stock opened at $4.55 and traded between $4.18 and $4.83 during that session. Session trading volume was 84K shares. The volume-weighted average price (VWAP) is $4.38.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Seres Therapeutics, Inc. has a market capitalization of $46.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MCRB is listed on the XNAS exchange. The company employs approximately 66 people. Seres Therapeutics, Inc. is headquartered in CAMBRIDGE, MA. The recorded listing date is 2015-06-26.
On this page you can find market MCRB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.